The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
Pavlick, Anna C;
Ariyan, Charlotte E;
Buchbinder, Elizabeth I;
Davar, Diwakar;
Gibney, Geoffrey T;
Hamid, Omid;
Hieken, Tina J;
Izar, Benjamin;
Johnson, Douglas B;
Kulkarni, Rajan P;
Luke, Jason J;
Mitchell, Tara C;
Mooradian, Meghan J;
Rubin, Krista M;
Salama, April K. S;
Shirai, Keisuke;
Taube, Janis M;
Tawbi, Hussein A;
Tolley, J Keith;
Valdueza, Caressa;
Weiss, Sarah A;
Wong, Michael K;
Sullivan, Ryan J.
Since the first approval for immune checkpoint inhibitors
(ICIs) for the treatment of cutaneous melanoma more than
a decade ago, immunotherapy has completely transformed
the treatment landscape of this chemotherapy-resistant
disease. Combination regimens including ICIs directed
against programmed cell de...
Brandsma, D;
Curigliano, G;
Furtner, J;
Le Rhun, E;
Minniti, G;
Peters, S;
Preusser, M;
Rudà, R;
Schadendorf, D;
Seoane, J;
Tonn, J. C;
van den Bent, M;
Weller, M;
Wick, W;
Wesseling, P.
These joint European Association of Neuro-Oncology (EANO)–European Society for Medical Oncology (ESMO) recommendations for the diagnosis and treatment of leptomeningeal metastasis (LM) from solid tumours provide an update of the first joint EANO–ESMO guideline1 and complement the EANO–ESMO guidelin...
NICE is unable to make a recommendation on teclistamab (Tecvayli) for treating relapsed or refractory multiple myeloma after 3 or more therapies in adults. This is because Agios did not provide an evidence submission. We will review this decision if the company decides to make a submission....
Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.
Commercial arrangement
There is a commercial arrangement for nivolumab. NHS organisations can get...
Elghazaly, Hesham;
Rugo, Hope;
Azim, Hamdy;
Swain, Sandra;
Arun, Banu;
Aapro, Matti;
Perez, Edith;
Anderson, Benjamin;
Penault-Llorca, Frederique;
Conte, Pierfranco.
The management of patients with triple-negative breast cancer (TNBC) is challenging with several controversies and unmet needs. During the 12th Breast-Gynaecological & Immuno-oncology International Cancer Conference (BGICC) Egypt, 2020, a panel of 35 breast cancer experts from 13 countries voted on conse...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del diagnóstico y tratamiento de personas con cáncer vesical. Personas con cáncer vesical que reciben atención en el nivel secundario y terciario de salud, en el sector público y privado de salud....
This guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over. It aims to improve care for people with non-Hodgkin's lymphoma by promoting the best tests for diagnosis and staging and the most effective treatments for 6 of the subtypes. Tests and treatments covered...
